ABL1 and acute lymphoblastic leukemia: In a BCR::ABL+ ALL mouse model, PD-L1 blockade led to clonal expansion of leukemia-specific CD4+T cells with a helper/cytotoxic phenotype, while reducing exhaustion marker expression (76).